Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFranchise Brands Regulatory News (FRAN)

Share Price Information for Franchise Brands (FRAN)

Share Price is delayed by 15 minutes
Get Live Data
143.00    -1.50 (-1.04%)
Bid:
143.00
Ask:
146.00
Spread: 3.00 (2.098%)
Market Cap: £274.10m
FRAN Live PriceLast checked at - London Stock Exchange

Intraday Franchise Brands Share Chart

Offer Update - acceptance, equity issue and TVR

21 Mar 2022 16:01

RNS Number : 4999F
Franchise Brands PLC
21 March 2022
Β 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION

Β 

Franchise BrandsΒ plc

Β 

Β 

Recommended All Share Offer

Β for

Filta Group Holdings plcΒ ("Filta")

by

Franchise BrandsΒ plc ("Franchise Brands")

Β 

Offer update - acceptance levels, issue of equity and Total Voting Rights

Β 

On 16 February 2022, Franchise Brands announced a recommended all share offer for Filta (the "Offer"), which became wholly unconditional on 10 March 2022. The full terms of, and conditions to, the Offer and the procedures for acceptance were set out in the offer document dated 18 February 2022 (the "Offer Document"). Terms used but not defined in this announcement have the same meaning as set out in the Offer Document.

Β 

Acceptance levels

Β 

Franchise Brands announces that, as at 3.07 p.m. on 18 March 2022, valid acceptances of the Offer had been received in respect of 24,945,697 Filta Shares, representing 85.42 per cent. of the issued share capital of Filta, to which the Offer relates.

Β 

The Offer will remain open for acceptances until further notice and 14 days' notice will be given ahead of the Offer closing.

Β 

Filta Shareholders who have not yet accepted the Offer are urged to do so as soon as possible in accordance with the procedure set out below.

Β 

Issue of equity

Β 

Pursuant to the Offer, a further 1,174,938 New Franchise Brands Shares will be issued in respect of valid acceptances received since 8 March 2022. Application has been made to the London Stock Exchange for these New Ordinary Shares to be admitted to trading on AIM ("Admission") and Admission is expected to take place on or around 22 March 2022. The New Franchise Brand Shares will rank pari passu in all respects with the Company's existing ordinary shares.

Β 

Total Voting Rights

Β 

Upon Admission, the total number of ordinary shares of 0.5p each in the Company ("Ordinary Shares") in issue will be 125,082,236. There are no ordinary shares held in treasury and therefore the total number of voting rights in the Company from Admission will be 125,082,236. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

Β 

Pursuant to Rule 17 of the AIM Rules for companies, the Company announces that Nigel Wray's (Non-Executive Director) interest in Ordinary Shares remains unchanged at 22,366,303 but upon Admission will represent 17.88 per cent. Of the Company's then issued share capital.

Β 

Β 

Cancellation of trading of Filta Shares on AIM

Β 

Filta announced on 9 March 2022 that, at the request of Franchise Brands, its Board has applied forΒ the cancellation of admission to trading on AIM of Filta Shares. It is anticipated that the cancellationΒ of admission to trading on AIMΒ will take effect on or shortly after 7.00 a.m. on 24 March 2022. Cancellation of admission to trading on AIM will significantly reduce the liquidity and marketability of all Filta Shares not assented to the Offer at that time.

Β 

Procedure for acceptance of the Offer

Β 

Filta Shareholders who have not yet accepted the Offer are urged to do so as soon as possible as follows:

Β 

Β· If you hold Filta Shares in certificated form (that is, not in CREST)

If you hold your Filta Shares, or any of them, in certificated form (that is, NOT in CREST), to accept the Offer in respect of those Filta Shares, you should complete and sign the personalised Form of Acceptance along with your valid share certificate(s) and/or any other relevant documents of title as soon as possible and return by post to the Receiving Agent, Computershare at Computershare Investor Services PLC, Corporate Actions Projects, Bristol BS99 6AH, United Kingdom.

Β 

Β· If you hold your Filta Shares in uncertificated form (that is, in CREST)

If you hold your Filta Shares, or any of them, in uncertificated form (that is, in CREST), to accept the Offer in respect of those Filta Shares, you should follow the procedure for Electronic Acceptance through CREST so that the TTE instruction settles as soon as possible.

Β 

Full details on how to accept the Offer are set out in the Offer Document, a copy of which is available on Franchise Brands' website atΒ https://www.franchisebrands.co.uk/investor-information/Β .Β Further copies of the Offer Document and the Form of Acceptance are available from ComputershareΒ by written request toΒ Computershare at Computershare Investor Services PLC, Corporate Actions Projects, Bristol BS99 6AH, United Kingdom or request to Computershare by telephone on (0370) 707 1807 (from within the UK) or on +44 370 707 1807 (from outside the UK).

Β 

Β 

Enquiries:

Β 

Franchise Brands plc

Stephen Hemsley, Executive Chairman

Chris Dent, Chief Financial Officer

Julia Choudhury, Corporate Development Director

Β 

+44 (0) 1625 813231

Filta Group Holdings plc

Jason Sayers, Chief Executive Officer

Brian Hogan, Chief Financial Officer

Β 

+1 407 996 5550

Allenby Capital Limited

Financial Adviser, Nominated Adviser and Joint Broker to Franchise Brands

Jeremy Porter / Liz Kirchner (Corporate Finance)

Amrit Nahal (Sales and Corporate Broking)

Β 

+44 (0) 20 3328 5656

Dowgate Capital Limited

Financial Adviser and Joint Broker to Franchise BrandsΒ Β 

James Serjeant / Russell Cook / Nicholas Chambers

Β 

+44 (0) 20 3903 7715

Cenkos Securities plc

Financial Adviser, Rule 3 Adviser, Nominated Adviser and Broker to Filta

Stephen Keys / Camilla Hume / Callum Davidson

Β 

+44 (0) 20 7397 8900

MHP Communications

PR advisers to Franchise Brands

Katie Hunt / Catherine Chapman

Β 

+44 (0) 20 3128 8100

+44 (0) 7884 494112

+44 (0) 7711 191518

franchisebrands@mhpc.com

Yellow Jersey PR

PR advisers to Filta

Charles Goodwin

Henry Wilkinson

+44 (0) 7747 788 221

+44 (0) 7951 402336

Β 

Β 

IMPORTANT NOTICES

Β 

Allenby Capital, which is authorised and regulated by the FCA in the UK, is acting as financial adviser, nominated adviser and joint broker exclusively for Franchise Brands and no one else in connection with the Offer and this announcement and will not be responsible to anyone other than Franchise Brands for providing the protections afforded to clients of Allenby Capital or for providing advice in relation to the Offer, the content of this announcement or any matter referred to herein.

Β 

Dowgate, which is authorised and regulated by the FCA in the UK, is acting as financial adviser and joint broker exclusively for Franchise Brands and no one else in connection with the Offer and this announcement and will not be responsible to anyone other than Franchise Brands for providing the protections afforded to clients of Dowgate or for providing advice in relation to the Offer, the content of this announcement or any matter referred to herein.

Β 

Cenkos,Β which is authorised and regulated by the FCA in the UK,Β is acting as financial adviser and Rule 3 adviser exclusively for Filta and no one else in connection with theΒ OfferΒ and the matters set out in this announcement and will not be responsible to any person other than Filta for providing the protections afforded to clients of Cenkos, nor for providing advice in relation to theΒ OfferΒ , the content of this announcement or any matter referred to herein.

Β 

Further Information

Β 

This announcement is for information purposes only and is not intended to and does not constitute or form part of an offer, invitation or the solicitation of an offer or invitation to purchase, or otherwise acquire, subscribe for, sell or otherwise dispose of any securities or the solicitation of any vote or approval in any jurisdiction pursuant to the Offer or otherwise nor shall there be any sale, issuance or transfer of securities of Franchise Brands or Filta pursuant to the Offer in any jurisdiction in contravention of applicable laws. The Offer will be implemented solely pursuant to the terms of the Offer Document (or, in the event that the Offer is to be implemented by means of a scheme, the Scheme Document), which contains the full terms and conditions of the Offer, including details of how to accept the Offer. Any decision in respect of, or other response to, the Offer should be made solely on the basis of the information contained in the Offer Document.

Β 

Allenby Capital and Cenkos urge Filta Shareholders to read the Offer Document carefully because it contains important information in relation to the Offer, the New Franchise Brands Shares and the Enlarged Group, and to take appropriate advice. Any action in relation to the Offer or related matters should be made only on the basis of the information contained in the Offer Document.

Β 

This announcement does not constitute a prospectus or prospectus equivalent document.

Β Β 

Overseas jurisdictions

Β 

The attention of Filta Shareholders who are citizens or residents of jurisdictions outside the UK (including guidance for US shareholders) is drawn to paragraph Part C of Appendix 1 of the Offer Document.

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
OUPPPUMAWUPPGAG
Date   Source Headline
10th Jun 202612:41 pmRNSShare Premium Cancellation
8th Jun 20264:38 pmRNSGrant of Options to director
26th May 202612:58 pmRNSGrant of Options to director
18th May 20267:00 amRNSAppointment of new CFO & Group Delivery Director
30th Apr 20264:01 pmRNSResult of General Meeting
30th Apr 20264:00 pmRNSResult of Annual General Meeting
30th Apr 20267:00 amRNSAGM Statement and Q1 Trading Update
7th Apr 202612:29 pmRNSHolding(s) in Company
31st Mar 20265:13 pmRNSProposed Share Premium cancellation
31st Mar 20265:13 pmRNSAnnual Report and Accounts & Notice of AGM
27th Mar 20267:00 amRNSGrant of Options to directors
27th Mar 20267:00 amRNSDirectors’ dealings
26th Mar 20267:00 amRNSDirectors' dealings
25th Mar 20267:00 amRNSFinal Results
18th Mar 20267:00 amRNS-RInvestor Presentation via Investor Meet Company
11th Mar 20263:13 pmRNSHolding(s) in Company
11th Mar 20263:13 pmRNSHolding(s) in Company
5th Mar 202611:17 amRNSHolding(s) in Company
5th Mar 20267:00 amRNSNotice of Results
2nd Mar 20262:00 pmRNSHolding(s) in Company
28th Jan 20267:00 amRNSTrading Update
21st Jan 20263:00 pmRNSHolding(s) in Company
21st Jan 20262:55 pmRNSHolding(s) in Company
12th Jan 20267:00 amRNSHolding(s) in Company
12th Nov 20257:00 amRNSQ3 Trading Update
3rd Nov 20252:00 pmRNSHolding(s) in Company
16th Oct 20257:00 amRNSDirectors’ dealings
14th Oct 20257:00 amRNSEBT share purchase programme update
9th Oct 20253:48 pmRNSDirectors’ dealings – Replacement
9th Oct 20257:00 amRNSDirectors' dealings
1st Oct 20255:00 pmRNSDirectors’ dealings
29th Sep 20256:05 pmRNSDirectors’ dealings
23rd Sep 20252:00 pmRNSHolding(s) in Company
5th Aug 20258:46 amRNSUpdate on potential listing
31st Jul 20251:52 pmRNSGrant of Options to director
30th Jul 20257:00 amRNSInterim Results
21st Jul 20257:00 amRNS-RInvestor Presentation via Investor Meet Company
7th Jul 20257:00 amRNSNotice of Interim Results
23rd Jun 20257:00 amRNS-RInclusion in FTSE AIM UK 50 Index
28th May 202511:06 amRNSHolding(s) in Company
19th May 20257:00 amRNSMove to SETS
7th May 20253:00 pmRNSResult of AGM
7th May 20257:00 amRNSAGM Statement and Q1 Trading Update
9th Apr 202510:00 amRNSDirectors' dealings
8th Apr 202510:00 amRNSDirectors' dealings
7th Apr 202510:00 amRNSDirectors’ dealings
4th Apr 20254:00 pmRNSHolding(s) in Company
2nd Apr 20259:00 amRNS-RInvestor Presentation via Investor Meet Company
1st Apr 20252:19 pmRNSAnnual Report and Accounts & Notice of AGM
31st Mar 202510:30 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.